Nike and golf equipment brand TaylorMade have signed endorsement deals with US golf star Nelly Korda, who became a free agent after her profile was removed from the Titleist website and partnership with Swedish clothing brand J.Lindeberg has ended.
The Nike deal makes Korda potentially the sportswear giant’s biggest women’s golf partner since it signed Michelle Wie West on a four-year deal reportedly worth US$20 million.
According to Korda, she signed with TaylorMade because of their proven ability to elevate the game of the best golfers in the world.
She added that with the TaylorMade tour team, she was not only working with high-performing equipment but also a team that shared her passion for working as hard as possible to be in the best position to win.
Dubbed the Tiger Woods of the Ladies Professional Golf Association (LPGA) Tour, the 24-year-old Korda could become the sport’s next leading icon.


Dollar Slips as Bond Market Stabilizes Amid Iran Tensions and Fed Rate Hike Expectations
Moody’s Downgrades Mexico Credit Rating Amid Rising Debt and Fiscal Pressure
Mistral AI Acquires Emmi AI to Expand Industrial AI Solutions in Europe
Samsung Union Confirms 18-Day Strike After Failed Wage Talks
JD Vance to Lead U.S. Presidential Delegation at Milano Cortina Winter Olympics Opening Ceremony
Republican Lawmakers Urge National Guard Role for World Cup Drone Security
Trump Threatens Stadium Deal Over Washington Commanders Name
Gold Prices Steady as Iran War Fuels Inflation and Rate Concerns
Fed’s Anna Paulson Signals Rates Could Stay Higher Longer Amid Inflation Risks
Google, Blackstone Launch $5B AI Cloud Venture to Challenge Nvidia and CoreWeave
Nvidia Beats Earnings Expectations as AI Demand Drives Record Growth
Asian Currencies Stay Rangebound as Dollar Holds Near Six-Week High Amid Iran War Concerns
Blackstone and Google Launch AI Cloud Venture, Pressuring CoreWeave and Nebius Shares
Stellantis CEO Antonio Filosa to Reveal Turnaround Strategy Focused on U.S. Sales and China Partnerships
Trump Attends Super Bowl Amid Cheers, Boos, and Political Divide
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme 



